- APEX Medical
-
PerformanceThe company's stock price closed at NT$28.1 on the TSE on Friday, May 13, 2022.The company has reported consolidated revenues of NT$201 million for April 2022, representing a 4.5% drop on month and 14.5% increase on year.For the fourth quarter of 2021, the company totaled NT$618 million in consolidated revenues, up 3.3% sequentially and up 11.7% on year.Brief
Full name: APEX Medical
Chinese name: 雃博股份有限公司
Short name: Apex
Stock code: 4106
Tax ID: 23632773
Market: TSE
Established: 17 Mar 1990
Paid in capital: NT$833.86 million
Listed on TSE: 8 Nov 2004
Listed on OTC: 22 Jan 2002
Listed on ESB: 2 Jan 2002
Public since: 19 Jul 1999
Website: cht.apexmedical.com.tw
-
-
Latest stock
Apex [4106] historical stock price (NT$) Date Volume (k) Transactions Value Open High Low Close Change Ask Bid 16-May 1,601 1,005 45,820,956 28.40 29.30 27.85 28.65 +0.55 +1.96% 28.60 28.65 13-May 1,757 1,076 48,945,291 27.60 28.30 27.25 28.10 +0.65 +2.37% 28.05 28.10 - Source: TSE, compiled by Digitimes
Latest salesApex: Consolidated revenues, Apr 2021 - Apr 2022 (NT$m)
Month
Sales
M/M
Y/Y
YTD
Y/Y
Apr-22
201
(4.5%)
14.5%
797
5.3%
Mar-22
211
9.2%
(11.9%)
595
2.5%
Feb-22
193
0.5%
19.2%
385
12.6%
Jan-22
192
(4.8%)
6.6%
192
6.6%
Dec-21
202
6.5%
0.5%
2,374
18.4%
Nov-21
189
(16.7%)
5.2%
2,172
20.4%
Oct-21
227
(3.3%)
30.1%
1,983
22%
Sep-21
235
30.7%
13.8%
1,756
21.1%
Aug-21
180
(2.2%)
24.1%
1,521
22.3%
Jul-21
184
(5.3%)
5.9%
1,341
22%
Jun-21
194
(6.1%)
11.7%
1,157
25.1%
May-21
207
17.6%
9.6%
963
28.2%
Apr-21
176
(26.4%)
20.5%
757
34.4%
*Figures are consolidated
Source: TSE, compiled by Digitimes, May 2022Apex: Consolidated revenues, 4Q20 - 4Q21 (NT$m)
Quarter
Sales
Q/Q
Y/Y
YTD
Y/Y
4Q-21
618
3.3%
11.7%
2,374
18.5%
3Q-21
598
3.8%
14%
1,756
21.1%
2Q-21
576
(0.8%)
13.4%
1,157
25.1%
1Q-21
581
4.9%
39.3%
581
39.3%
4Q-20
554
5.5%
7.2%
2,004
(1.6%)
*Figures are consolidated
Source: TSE, compiled by Digitimes, May 2022Latest balance sheet and income statementApex: Consolidated balance sheet, 4Q20 - 4Q21 (NT$k)
Item
4Q-2021
3Q-2021
2Q-2021
1Q-2021
4Q-2020
Current assets
1,588,014
1,571,775
1,569,157
1,469,606
1,405,183
Intangible assets
668,069
671,722
689,911
701,977
701,672
Non-current assets
1,552,403
1,546,030
1,582,452
1,609,352
1,641,226
Assets
3,140,417
3,117,805
3,151,609
3,078,958
3,046,409
Current liabilities
873,877
805,574
773,474
707,845
709,855
Non-current liabilities
202,250
232,625
245,479
251,087
230,271
Liabilities
1,076,127
1,038,199
1,018,953
958,932
940,126
Stockholders' equity
2,064,290
2,079,606
2,132,656
2,120,026
2,106,283
*Figures are consolidated
Source: TSE, compiled by Digitimes, May 2022Apex: Consolidated income statement, 4Q20 - 4Q21 (NT$k)
Item
4Q-2021
3Q-2021
2Q-2021
1Q-2021
4Q-2020
NT$k
% of sales
NT$k
% of sales
NT$k
% of sales
NT$k
% of sales
NT$k
% of sales
Gross sales
0
576,441
580,866
0
Operating revenue
618,333
598,415
576,441
580,866
553,793
Gross profit (loss) from operations
243,185
248,590
249,786
245,391
217,793
Operating expenses
248,231
214,626
220,868
198,904
217,181
Operating income (loss)
-5,046
33,964
28,918
46,487
612
Non-operating expenses and losses
13,883
12,262
12,218
-4,605
9,122
Income from continuing operations before income tax
8,837
46,226
41,136
41,882
9,734
Net income (loss)
7,528
31,182
35,126
29,675
14,531
Diluted earnings per share (NT$)
0.1
0.3
0.3
0.3
0.1
*Figures are consolidated
Source: TSE, compiled by Digitimes, May 2022 - APEX Medical full profile